keyword
https://read.qxmd.com/read/38643357/successful-treatment-of-lithium-induced-nephrogenic-diabetes-insipidus-with-celecoxib-a-promising-therapeutic-option
#1
JOURNAL ARTICLE
Ryunosuke Hahsikawa, Hiroyuki Yamada, Toshihito Fujii, Shigeru Ohtsuru
BACKGROUND Nephrogenic diabetic insipidus (NDI) poses a challenge in clinical management, particularly when associated with lithium ingestion. Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used for the treatment of numerous diseases worldwide, including NDI. However, many studies have reported the diverse adverse effects of long-term use of non-selective NSAIDs. Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is a better drug to relieve pain and inflammation in terms of long-term safety and efficacy than non-selective NSAIDs...
April 21, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38641308/celecoxib-and-sulindac-sulfide-elicit-anticancer-effects-on-pik3ca-mutated-head-and-neck-cancer-cells-through-endoplasmic-reticulum-stress-reactive-oxygen-species-and-mitochondrial-dysfunction
#2
JOURNAL ARTICLE
Nga Thi Thanh Nguyen, Sang Yoon Lee
Gain-of-function mutation in the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) catalytic subunit alpha gene (PIK3CA) is a significant factor in head and neck cancer (HNC). Patients with HNC harboring PIK3CA mutations receive therapeutic benefits from the use of non-steroidal anti-inflammatory drugs (NSAIDs). However, the molecular mechanisms underlying these effects remain unknown. Here, we examined the Detroit562 and FaDu cell lines as HNC models with and without a hyperactive PIK3CA mutation (H1047R), respectively, regarding their possible distinct responses to the NSAIDs celecoxib and sulindac sulfide (SUS)...
April 17, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38639393/exploring-of-novel-oxazolones-and-imidazolones-as-anti-inflammatory-and-analgesic-candidates-with-cyclooxygenase-inhibitory-action
#3
JOURNAL ARTICLE
Seham A Rayan, Riham F George, Nada M Mohamed, Mona F Said
Aim: Over the last few decades, therapeutic needs have led to a search for safer COX-2 inhibitors with potential anti-inflammatory and analgesic activity. Materials & methods: A new series of oxazolone and imidazolone derivatives 3a-c and 4a-r were synthesized and evaluated as anti-inflammatory and analgesic agents. COX-1/COX-2 isozyme selectivity testing and molecular docking were performed. Results: All compounds showed good activities comparable to those of the reference, celecoxib. The most active compounds 3a , 4a , 4c , 4e and 4f showed promising gastric tolerability with an ulcer index lower than that of celecoxib...
April 19, 2024: Future Medicinal Chemistry
https://read.qxmd.com/read/38626522/exploration-of-isoxazole-analogs-synthesis-cox-inhibition-anticancer-screening-3d-multicellular-tumor-spheroids-and-molecular-modeling
#4
JOURNAL ARTICLE
Mohammed Hawash, Samer Abdallah, Mahmoud Abudayyak, Yarob Melhem, Mohammed Abu Shamat, Meera Aghbar, Irfan Çapan, Murad Abualhasan, Anil Kumar, Michał Kamiński, Tomasz Góral, Paulina Maria Dominiak, Shorooq Sobuh
In this study, a new series of Isoxazole-carboxamide derivatives were synthesized and characterized via HRMS, 1 H-, 13 CAPT -NMR, and MicroED. The findings revealed that nearly all of the synthesized derivatives exhibited potent inhibitory activities against both COX enzymes, with IC50 values ranging from 4.1 nM to 3.87 μM. Specifically, MYM1 demonstrated the highest efficacy among the compounds tested against the COX-1, displaying an IC50 value of 4.1 nM. The results showed that 5 compounds possess high COX-2 isozyme inhibitory effects with IC50 value in range 0...
April 15, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38618296/efficacy-of-electroacupuncture-combined-with-chinese-herbal-medicine-on-pain-intensity-for-chronic-sciatica-secondary-to-lumbar-disc-herniation-study-protocol-for-a-randomised-controlled-trial
#5
JOURNAL ARTICLE
Jing-Chun Xia, Yu-Cheng Huang, Ke Wu, Jian Pang, Ying Shi
PURPOSE: Chinese herbal medicine and electroacupuncture (EA) have been used to control pain for many decades in China. We aim to explore the efficacy of intervening patients whose discogenic sciatica symptoms lasting longer than 3 months with these conservative treatments. PATIENTS AND METHODS: This is a single-center, parallel-group, patient-unblinded Randomized Controlled Trial (RCT) with blinded outcome assessment and statistician. One hundred and twenty-four patients will be assigned randomly into 2 groups including conservative treatment group (Shenxie Zhitong capsule combined with EA treatment) and Nonsteroidal Anti-inflammatory Drugs (Nonsteroidal Anti-inflammatory Drugs, NSAIDs) control group (Celecoxib) in a 1:1 ratio...
2024: Journal of Pain Research
https://read.qxmd.com/read/38611123/the-effect-of-different-factors-on-poly-lactic-co-glycolic-acid-nanoparticle-properties-and-drug-release-behaviors-when-co-loaded-with-hydrophilic-and-hydrophobic-drugs
#6
JOURNAL ARTICLE
Lianguo Wang, Pei Wang, Yifan Liu, Muhammad Atae Mustafa Mahayyudin, Rong Li, Weilun Zhang, Yilan Zhan, Zhihua Li
Poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs) are versatile drug nanocarriers with a wide spectrum of applications owing to their extensive advantages, including biodegradability, non-toxic side effects, and low immunogenicity. Among the numerous nanoparticle preparation methods available for PLGA NPs (the hydrophobic polymer), one of the most extensively utilized preparations is the sonicated-emulsified solvent evaporation method, owing to its simplicity, speed, convenience, and cost-effectiveness...
March 22, 2024: Polymers
https://read.qxmd.com/read/38608422/cause-and-chondroprotective-effects-of-prostaglandin-e2-secretion-during-mesenchymal-stromal-cell-chondrogenesis
#7
JOURNAL ARTICLE
Sven Schmidt, Felicia A M Klampfleuthner, Tobias Renkawitz, Solvig Diederichs
Mesenchymal stromal cells (MSCs) that are promising for cartilage tissue engineering secrete high amounts of prostaglandin E2 (PGE2), an immunoactive mediator involved in endochondral bone development. This study aimed to identify drivers of PGE2 and its role in the inadvertent MSC misdifferentiation into hypertrophic chondrocytes. PGE2 release, which rose in the first three weeks of MSC chondrogenesis, was jointly stimulated by endogenous BMP, WNT, and hedgehog activity that supported the exogenous stimulation by TGF-β1 and insulin to overcome the PGE2 inhibition by dexamethasone...
April 7, 2024: European Journal of Cell Biology
https://read.qxmd.com/read/38596158/comparison-of-pain-management-strategies-to-reduce-opioid-use-postoperatively-in-free-flap-breast-reconstruction-pain-catheter-versus-nerve-block-in-addition-to-refinements-in-the-oral-pain-management-regime
#8
JOURNAL ARTICLE
Andrea B Stefansdottir, Luis Vieira, Arni Johnsen, Daniel Isacson, Andres Rodriguez, Maria Mani
Background  Perioperative management in autologous breast reconstruction has gained focus in recent years. This study compares two pain management protocols in patients undergoing abdominal-based free flap breast reconstruction: a past protocol (PP) and a current protocol (CP)-both intended to reduce opioid consumption postoperatively. The PP entails use of a pain catheter in the abdominal wound and the CP consists of an intraoperative nerve block in addition to refinements in the oral pain management...
March 2024: Archives of Plastic Surgery
https://read.qxmd.com/read/38584541/recent-advancements-in-refashioning-of-nsaids-and-their-derivatives-as-anticancer-candidates
#9
JOURNAL ARTICLE
Asmaa E Kassab, Ehab M Gedawy
Inflammation is critical to the formation and development of tumors and is closely associated with cancer. Therefore, addressing inflammation and the mediators that contribute to the inflammatory process may be a useful strategy for both cancer prevention and treatment. Tumor predisposition can be attributed to inflammation. It has been demonstrated that NSAIDs can modify the tumor microenvironment by enhancing apoptosis and chemosensitivity and reducing cell migration. There has been a recent rise in interest in drug repositioning or repurposing because the development of innovative medications is expensive, timeconsuming, and presents a considerable obstacle to drug discovery...
April 5, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38582102/a-low-transition-temperature-mixture-based-viscosupplementation-complemented-with-celecoxib-for-osteoarthritis-treatment
#10
JOURNAL ARTICLE
Ana Roda, Alexandre Paiva, Ana Rita C Duarte
Viscosupplementation consists of hyaluronic acid (HA) intra-articular injections, commonly applied for osteoarthritis treatment while non-steroidal anti-inflammatory drugs (NSAID) are widely administered for pain relief. Here, HA and NSAID (celecoxib) were combined in a formulation based on a low transition temperature mixture (LTTM) of glycerol:sorbitol, reported to increase celecoxib's solubility, thus rendering a potential alternative viscosupplement envisioning enhanced therapeutic efficiency. The inclusion of glucosamine, a cartilage precursor, was also studied...
April 4, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38574911/injectable-self-healing-hydrogels-based-on-gelatin-quaternized-chitosan-and-laponite-as-localized-celecoxib-delivery-system-for-nucleus-pulpous-repair
#11
JOURNAL ARTICLE
Maryam Nezadi, Hamid Keshvari, Fatemeh Shokrolahi, Parvin Shokrollahi
Utilization of injectable hydrogels stands as a paradigm of minimally invasive intervention in the context of intervertebral disc degeneration treatment. Restoration of nucleus pulposus (NP) function exerts a profound influence in alleviating back pain. This study introduces an innovative class of injectable shear-thinning hydrogels, founded on quaternized chitosan (QCS), gelatin (GEL), and laponite (LAP) with the capacity for sustained release of the anti-inflammatory drug, celecoxib (CLX). First, synthesis of Magnesium-Aluminum-Layered double hydroxide (LDH) was achieved through a co-precipitation methodology, as a carrier for celecoxib and a source of Mg ions...
April 2, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38570607/unveiling-the-methionine-cycle-a-key-metabolic-signature-and-nr4a2-as-a-methionine-responsive-oncogene-in-esophageal-squamous-cell-carcinoma
#12
JOURNAL ARTICLE
Xing Jin, Lei Liu, Dan Liu, Jia Wu, Congcong Wang, Siliang Wang, Fengying Wang, Guanzhen Yu, Xiaoxia Jin, Yu-Wen Xue, Dan Jiang, Yan Ni, Xi Yang, Ming-Song Wang, Zhi-Wei Wang, Yuriy L Orlov, Wei Jia, Gerry Melino, Ji-Bin Liu, Wen-Lian Chen
Esophageal squamous cell carcinoma (ESCC) is a deadly malignancy with notable metabolic reprogramming, yet the pivotal metabolic feature driving ESCC progression remains elusive. Here, we show that methionine cycle exhibits robust activation in ESCC and is reversely associated with patient survival. ESCC cells readily harness exogenous methionine to generate S-adenosyl-methionine (SAM), thus promoting cell proliferation. Mechanistically, methionine augments METTL3-mediated RNA m6 A methylation through SAM and revises gene expression...
April 3, 2024: Cell Death and Differentiation
https://read.qxmd.com/read/38569433/a-series-of-indole-derived-%C3%AE-hydroxy-propiolate-esters-as-potent-anti-inflammatory-agents-design-synthesis-in-vitro-and-in-vivo-biological-studies
#13
JOURNAL ARTICLE
Maryam Akhtar, Luhao Lai, Ting Tian, Xu Zhang, Hao Cheng, Li Lin
A variety of novel indole-derived γ-hydroxy propiolate esters were designed, synthesized, and evaluated for their anti-inflammatory activity in-vitro and in-vivo. According to the nitric oxide (NO) inhibitory analysis, all compounds showed potent NO inhibitory ability in a dose-dependent manner, with no apparent cytotoxicity. The model compound, L-37, also exhibited significant potency in PGE2 inhibition. In addition, compounds L-37 and L-39 can downregulate the expression of COX-2 enzyme at 5 μM via ELISA experiment...
March 30, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38563392/prevented-cell-clusters-migration-via-microdot-biomaterials-for-inhibiting-scar-adhesion
#14
JOURNAL ARTICLE
Yaping Zhuang, Feng Lin, Lei Xiang, Zhengwei Cai, Fei Wang, Wenguo Cui
Cluster-like collective cell migration of fibroblasts is one of the main factors of adhesion in injured tissues. In this research, a microdot biomaterial system was constructed using α-helical polypeptide nanoparticles and anti-inflammatory micelles, which were prepared by ring-opening polymerization of α-amino acids-N-carboxylic anhydrides (NCAs) and lactide, respectively. The microdot biomaterial system slowly released functionalized polypeptides targeting mitochondria and promoting the influx of extracellular calcium ions under the inflammatory environment, thus inhibiting the expression of N-cadherin mediating cell-cell interaction, and promoting apoptosis of cluster fibroblasts, synergistically inhibiting the migration of fibroblast clusters at the site of tendon injury...
April 2, 2024: Advanced Materials
https://read.qxmd.com/read/38561067/exploring-the-effect-of-protein-secondary-structure-on-the-solid-state-and-physical-stability-of-protein-based-amorphous-solid-dispersions
#15
JOURNAL ARTICLE
Xuezhi Zhuo, Julia Ochner, Donglei Leng, Vito Foderà, Korbinian Löbmann
Amorphous solid dispersions (ASDs) using proteins as carriers have emerged as a promising strategy for stabilizing amorphous drug molecules. Proteins possess diverse three-dimensional structures that significantly influence their own properties and may also impact the properties of ASDs. We prepared β-lactoglobulin (BLG) with different contents of β-sheet and α-helical secondary structures by initially dissolving BLG in different mixed solvents, containing different ratios of water, methanol/ethanol, and acetic acid, followed by spray drying of the solutions...
March 30, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38559550/elderly-woman-with-no-autoimmune-disease-with-aseptic-meningitis-caused-by-celecoxib
#16
Masaki Takigawa, Hiroyuki Tanaka, Takashi Kobayashi, Yuto Katahara, Masako Kinoshita, Masayuki Masuda, Rika Iwakiri
Nonsteroidal anti-inflammatory drug (NSAID)-induced aseptic meningitis (NIAM) is frequently reported in patients with autoimmune disease. Ibuprofen-induced NIAM is the most common case report of NIAM. We report a patient without autoimmune disease who developed NIAM following oral celecoxib administration. A literature review and survey of cases registered in the Japanese Adverse Drug Event Report (JADER) database is also provided. A 73-year-old woman with no autoimmune disease developed a headache the day after taking celecoxib, and NIAM was suspected...
March 2024: Curēus
https://read.qxmd.com/read/38557656/analgesic-and-anti-inflammatory-effects-of-galangin-a-potential-pathway-to-inhibit-transient-receptor-potential-vanilloid-1-receptor-activation
#17
JOURNAL ARTICLE
Kaiwen Lin, Datian Fu, Zhongtao Wang, Xueer Zhang, Canyang Zhu
BACKGROUND: Galangin, commonly employed in traditional Chinese medicine for its diverse medicinal properties, exhibits potential in treating inflammatory pain. Nevertheless, its mechanism of action remains unclear. METHODS: Mice were randomly divided into 4 groups for 7 days: a normal control group, a galangin-treated (25 and 50 mg/kg), and a positive control celecoxib (20 mg/kg). Analgesic and anti-inflammatory effects were evaluated using a hot plate test, acetic acid-induced writhing test, acetic acid-induced vascular permeability test, formalininduced paw licking test, and carrageenan-induced paw swelling test...
April 1, 2024: Korean Journal of Pain
https://read.qxmd.com/read/38550490/an-atypical-case-of-spondylitis-due-to-nontyphoidal-salmonella-in-an-adult-patient-a-case-report-and-review-of-the-literature
#18
Toru Hamada, Shinya Furukawa, Yoshio Kikuchi, Masashi Kubota, Eiji Mitsunaga
Nontyphoidal Salmonella commonly induces intestinal infections; however, spondylitis arising from this bacterium is exceedingly rare. A comprehensive review of the clinical attributes of nontyphoidal Salmonella-induced spondylitis in adult populations is lacking in the literature. We report a case of an 83-year-old female who presented with a fever lasting three days, accompanied by anorexia and pervasive malaise. A month prior, she had been prescribed celecoxib and had received a trigger point injection. The patient was initially diagnosed with acute pyelonephritis and treated with an antimicrobial regimen...
February 2024: Curēus
https://read.qxmd.com/read/38542198/repurposed-drugs-celecoxib-and-fmoc-l-leucine-alone-and-in-combination-as-temozolomide-resistant-antiglioma-agents-comparative-studies-on-normal-and-immortalized-cell-lines-and-on-c-elegans
#19
JOURNAL ARTICLE
Łukasz Uram, Natalia Pieńkowska, Maria Misiorek, Żaneta Szymaszek, Magdalena Twardowska, Michał Siorek, Stanisław Wołowiec
Glioblastoma multiforme therapy remains a significant challenge since there is a lack of effective treatment for this cancer. As most of the examined gliomas express or overexpress cyclooxygenase-2 (COX-2) and peroxisome proliferator-activated receptors γ (PPARγ), we decided to use these proteins as therapeutic targets. Toxicity, antiproliferative, proapoptotic, and antimigratory activity of COX-2 inhibitor (celecoxib-CXB) and/or PPARγ agonist (Fmoc-L-Leucine-FL) was examined in vitro on temozolomide resistant U-118 MG glioma cell line and comparatively on BJ normal fibroblasts and immortalized HaCaT keratinocytes...
March 12, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38536949/combination-nano-delivery-systems-remodel-the-immunosuppressive-tumor-microenvironment-for-metastatic-triple-negative-breast-cancer-therapy
#20
JOURNAL ARTICLE
Liya Bai, Hui Liu, Ran You, Xiaoyu Jiang, Tao Zhang, Yunan Li, Tianhe Shan, Zhanyin Qian, Yinsong Wang, Yuanyuan Liu, Chunyu Li
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer for which effective therapies are lacking. Targeted remodeling of the immunosuppressive tumor microenvironment (TME) and activation of the body's immune system to fight tumors with well-designed nanoparticles have emerged as pivotal breakthroughs in tumor treatment. To simultaneously remodel the immunosuppressive TME and trigger immune responses, we designed two potential therapeutic nanodelivery systems to inhibit TNBC. First, the bromodomain-containing protein 4 (BRD4) inhibitor JQ1 and the cyclooxygenase-2 (COX-2) inhibitor celecoxib (CXB) were coloaded into chondroitin sulfate (CS) to obtain CS@JQ1/CXB nanoparticles (NPs)...
March 27, 2024: Molecular Pharmaceutics
keyword
keyword
13321
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.